BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 14529420)

  • 1. Application of chitin and chitosan derivatives in the pharmaceutical field.
    Kato Y; Onishi H; Machida Y
    Curr Pharm Biotechnol; 2003 Oct; 4(5):303-9. PubMed ID: 14529420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and drug-release characteristics of the conjugates of mitomycin C with N-succinyl-chitosan and carboxymethyl-chitin.
    Song Y; Onishi H; Nagai T
    Chem Pharm Bull (Tokyo); 1992 Oct; 40(10):2822-5. PubMed ID: 1464115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-succinyl-chitosan as a drug carrier: water-insoluble and water-soluble conjugates.
    Kato Y; Onishi H; Machida Y
    Biomaterials; 2004 Feb; 25(5):907-15. PubMed ID: 14609679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chitosan microparticles for mucosal vaccination against diphtheria: oral and nasal efficacy studies in mice.
    van der Lubben IM; Kersten G; Fretz MM; Beuvery C; Coos Verhoef J; Junginger HE
    Vaccine; 2003 Mar; 21(13-14):1400-8. PubMed ID: 12615436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chitosan and its use as a pharmaceutical excipient.
    Illum L
    Pharm Res; 1998 Sep; 15(9):1326-31. PubMed ID: 9755881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mucoadhesive vaginal tablets as veterinary delivery system for the controlled release of an antimicrobial drug, acriflavine.
    Gavini E; Sanna V; Juliano C; Bonferoni MC; Giunchedi P
    AAPS PharmSciTech; 2002; 3(3):E20. PubMed ID: 12916935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The characteristics of betamethasone-loaded chitosan microparticles by spray-drying method.
    Huang YC; Yeh MK; Cheng SN; Chiang CH
    J Microencapsul; 2003; 20(4):459-72. PubMed ID: 12851046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biological fate of highly-succinylated N-succinyl-chitosan and antitumor characteristics of its water-soluble conjugate with mitomycin C at i.v. and i.p. administration into tumor-bearing mice.
    Kato Y; Onishi H; Machida Y
    Biol Pharm Bull; 2000 Dec; 23(12):1497-503. PubMed ID: 11145185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo drug release and antitumor characteristics of water-soluble conjugates of mitomycin C with glycol-chitosan and N-succinyl-chitosan.
    Sato M; Onishi H; Takahara J; Machida Y; Nagai T
    Biol Pharm Bull; 1996 Sep; 19(9):1170-7. PubMed ID: 8889036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic characteristics and antitumor activity of the N-succinyl-chitosan-mitomycin C conjugate and the carboxymethyl-chitin-mitomycin C conjugate.
    Song Y; Onishi H; Nagai T
    Biol Pharm Bull; 1993 Jan; 16(1):48-54. PubMed ID: 8369752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chitosan-gadopentetic acid complex nanoparticles for gadolinium neutron-capture therapy of cancer: preparation by novel emulsion-droplet coalescence technique and characterization.
    Tokumitsu H; Ichikawa H; Fukumori Y
    Pharm Res; 1999 Dec; 16(12):1830-5. PubMed ID: 10644070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contribution of chitosan and its derivatives to cancer chemotherapy.
    Kato Y; Onishi H; Machida Y
    In Vivo; 2005; 19(1):301-10. PubMed ID: 15796190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biodisposition characteristics of N-succinyl-chitosan and glycol-chitosan in normal and tumor-bearing mice.
    Kamiyama K; Onishi H; Machida Y
    Biol Pharm Bull; 1999 Feb; 22(2):179-86. PubMed ID: 10077438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic efficacy of sustained drug release from chitosan gel on local inflammation.
    Kofuji K; Akamine H; Qian CJ; Watanabe K; Togan Y; Nishimura M; Sugiyama I; Murata Y; Kawashima S
    Int J Pharm; 2004 Mar; 272(1-2):65-78. PubMed ID: 15019070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chitosan: a unique polysaccharide for drug delivery.
    Felt O; Buri P; Gurny R
    Drug Dev Ind Pharm; 1998 Nov; 24(11):979-93. PubMed ID: 9876553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanoparticles of 5-fluorouracil (5-FU) loaded N-succinyl-chitosan (Suc-Chi) for cancer chemotherapy: preparation, characterization--in-vitro drug release and anti-tumour activity.
    Yan C; Chen D; Gu J; Qin J
    J Pharm Pharmacol; 2006 Sep; 58(9):1177-81. PubMed ID: 16945175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation and in vitro properties of N-succinylchitosan- or carboxymethylchitin-mitomycin C conjugate microparticles with specified size.
    Onishi H; Takahashi H; Yoshiyasu M; Machida Y
    Drug Dev Ind Pharm; 2001 Aug; 27(7):659-67. PubMed ID: 11694013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of chitosan and sodium alginate and formulation variables on the formation and drug release from pellets prepared by extrusion/spheronisation.
    Chatchawalsaisin J; Podczeck F; Newton JM
    Int J Pharm; 2004 May; 275(1-2):41-60. PubMed ID: 15081137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Application of chitin and its derivatives to pharmaceutical industry for traditional Chinese medicine].
    Zhou B; Gao WY; Zhang TJ; Chen HX
    Zhongguo Zhong Yao Za Zhi; 2005 Sep; 30(17):1313-6. PubMed ID: 16323536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross-linked chitosan microspheres as carriers for prolonged delivery of macromolecular drugs.
    Jameela SR; Misra A; Jayakrishnan A
    J Biomater Sci Polym Ed; 1994; 6(7):621-32. PubMed ID: 7873513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.